CONTEXT: Ordinarily we wouldn’t post news about RCT studies. However, the thing that caught our eye in this article is the need to point out that the research question they Continue Reading
CONTEXT: Peer reviewed retrospective study of a triple oral combination therapy in PAH | Japan only data. IMPACT: medium READ TIME: 2 mins Quality Level Mean [1 – 10]: 8 Continue Reading
CONTEXT: Short article but nice explainer video on why RWR is so important in oncology research IMPACT: Medium READ TIME: 1 min Quality Level Mean [1 – 10]: 8 1. Continue Reading
CONTEXT: ICER using RWE predominantly for economic reviews and seldom in effectiveness evaluations. IMPACT: mediumREAD TIME: 2 mins Quality Level Mean [1 – 10]: 7 1. “Real-world evidence is used Continue Reading
CONTEXT: Long term treatment effect study of a rare disease (LOPD) | Relatively low patient numbers for RWR, but the findings just as powerful for this rare disease. IMPACT: Continue Reading
CONTEXT: No great surprise the MS patients are at a higher risk of infections, but good use of retrospective data analyses to see exactly what is going on – well Continue Reading
CONTEXT: Summary article on the continuing interest and need for RWR, fuelled by the COVID pandemic. IMPACT: Low READ TIME: 2 mins Quality Level Mean [1 – 10]: 5 1. Continue Reading
CONTEXT: A company looking to explore new ways to expand the use of RWD in drug development. By utilising the power of RWD to look at treatment models overall, it Continue Reading
CONTEXT: RWE is not confined to the world of health care and pharmaceuticals. This article explores RWE in climate change policy effectiveness. IMPACT: Low READ TIME: 1 min 1. “The Continue Reading
CONTEXT: Commercial announcement of an RWE market analysis report. Unsurprisingly buoyant predictions of double digit growth forecasts across the board. IMPACT: low READ TIME: 5 mins Quality Level Mean [1 – Continue Reading
